Jeffrey Gould Moore

Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA.

Part of Acacia Capital Corp., Biolink Corp. is a company that distributes marine livestock. The company is based in El Segundo, CA. Biolink was acquired by Acacia Capital Corp. on April 08, 2002.

Modular Genetics, Inc. designs and develops engineered microorganisms that synthesize chemicals. Its proprietary advanced technology in synthetic biology to produce products that are cost competitive, provide superior performance and are environmentally friendly. The firm’s technology can be used in various areas that include bioplastics, semisynthetic drugs, biodiesel, biosurfactants, and commodity chemical feedstocks. The company was founded by Kevin A. Jarrell and Temple F. Smith in 2000 and is headquartered in Woburn, MA.

Infraredx, Inc. is a developed cardiovascular imaging devices. Its product were TVC Imaging System dual-modality intravascular imaging system with the ability to assess vessel structure and plaque composition via integrated NIRS near infrared spectroscopy lipid-core plaque LCP detection and enhanced IVUS imaging technology. The company was founded by James E. Muller in 1999 and is headquartered in Bedford, MA.

The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009.

Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA.

Epistem Ltd. engages in the provision of research solutions. It offers laser capture microdissection, imaging; microbiome, gene expression, NGS, DNA genotyping, and plucked hair analysis; Histology and IHC, and analytical services. The company was founded by Christopher Stanislaus Potten, Catherine Booth and Julie Tudor in 2000 and is headquartered in Manchester, the United Kingdom.

The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

Charles River CFO, Inc. provides financial management services. Its offers strategic transaction services, outsourced accounting and finance, financial management resources, finance, accounting and tax services. The company was founded by Ann Vickers and Connie Wright in 2003 and is headquartered in Newton, MA.

Massachusetts Society of Certified Public Accountants, Inc. provide services in public accounting, industry and business, government and education. The firm offers advocacy, continuing professional education, peer review, membership, communications and academic and career development department. The company was founded in 1900 and is headquartered in Boston, MA.

Continum Group Ltd. engages in the innovative business driven information technology and communications products and solutions. It operates in the followng divisions: Continum 42, Continum, Xempower, and 4 Business Calls. The Continum 42 handles the research and development facilities. The Continum refers to the innovative IT and communication solutions. The Xempower manages hosted applications and IT platforms. The 4 Business Calls manages hosted telephony solutions. The company is headquartered in Bury, the United Kingdom.

Atlantis Healthcare Group Ltd. develops and distributes software related to patient support services. It engages in designing, implementing and operating patient support and adherence programs for the pharmaceutical and other health related industries. The firm’s solutions include self-management behaviors, understanding behavior change, solutions for the patient journey, behavior change techniques and personalized program. The company is headquartered in Auckland, New Zealand.

Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA.

Biobeats Group Ltd. engages in the design and development of mobile software applications. It offers BioBase app. The company was founded by Nadeem Iqbal Kassam, David Plans and Davide Morelli in 2013 and is headquartered in London, the United Kingdom.

The Friedreich's Ataxia Research Alliance provides patient registry services. The private company is based in Downingtown, PA.

Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD.

NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom.

The Fertility Partnership Ltd. provides fertility services. Its services include surgical sperm retrieval, time lapse imaging, embryoglue and assisted hatching. The company was founded by David Elan Simckes in 1985 and is headquartered in Oxford, the United Kingdom.

Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom.

Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA.

T-Cure Bioscience, Inc. is an innovative immuno-oncology company based in Sherman Oaks, CA. The private company maintains a pipeline of TCR under clinical and pre-clinical development targeting HERV-E, KK-LC-1, NY-ESO-1, and other antigens associated with solid tumors of significant unmet medical needs, including kidney cancer, breast cancer, lung cancer, gastric cancer, ovarian cancer, liver cancer, pancreatic cancer, sarcoma, and glioblastoma. The CEO of the company is Gang Zeng.